Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.990
-0.020 (-0.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 21 employees as of December 31, 2023. The number of employees decreased by 6 or -22.22% compared to the previous year.
Employees
21
Change (1Y)
-6
Growth (1Y)
-22.22%
Revenue / Employee
$4,995
Profits / Employee
-$410,371
Market Cap
2.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Venus Concept | 304 |
| Xylo Technologies | 84 |
| Aptevo Therapeutics | 40 |
| Bluejay Diagnostics | 10 |
| Palisade Bio | 9 |
| Shuttle Pharmaceuticals Holdings | 8 |
| Dermata Therapeutics | 8 |
| IMAC Holdings | 4 |
BDRX News
- 4 weeks ago - Result of General Meeting - GlobeNewsWire
- 4 weeks ago - Gaining Momentum, Biodexa is Advancing Two Recent Acquisitions Through the Clinic - Accesswire
- 5 weeks ago - Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq - GlobeNewsWire
- 6 weeks ago - Notice of General Meeting - GlobeNewsWire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biodexa Pharmaceuticals Plc (BDRX) And Encourages Shareholders to Reach Out - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Biodexa Pharmaceuticals Plc (BDRX) and Encourages Investors to Learn More About the Investigation - Accesswire
- 7 weeks ago - Biodexa Pharmaceuticals Plc (BDRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 7 weeks ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Biodexa Pharmaceuticals Plc (BDRX) And Encourages Stockholders to Reach Out - Accesswire